DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Kim SB, Dent R, Im SA. et al.
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Lancet Oncol 2017;
18: 1360-1372

Download Bibliographical Data

Search in:
Access:
Access: